OncoBites
banner
oncobites.bsky.social
OncoBites
@oncobites.bsky.social
Cancer professionals & advocates sharing cutting-edge #CancerResearch with non-specialists in bite-sized pieces.

https://oncobites.blog
Pinned
OncoBites is now on Bluesky! Please follow us for the latest in #cancerresearch simplified into bite-sized pieces!
Cell-penetrating peptides deliver drugs directly into cells but lack cell-type specificity. Scientists developed a new peptide-like compound that can take better advantage of the slightly acidic tumor environment to target cancer cells. Anamika Bandyopadhyay writes.

oncobites.blog/2026/02/04/t...
Teaching drugs to find Cancer: pH-sensitive Peptidomimetics at play!
Reading time: 5 minutes Anamika Bandyopadhyay, PhDChemotherapy transformed cancer treatments in the 20th century, but its lack of specificity remained a major limitation throughout. As time progres…
oncobites.blog
February 4, 2026 at 9:29 PM
Why is cancer screening important, what current screening methods exist for some common cancers, and what can you do to help reduce your risk of cancer? Read this article to learn more. Dr. Preeti Roman writes.

oncobites.blog/2026/01/28/c...
Cancer Screening and Prevention
Reading time: 3 minutes Dr. Preeti Roman Cancer is a major cause of sickness and death worldwide1. In 2022, doctors found 20 million new cancer cases2 and nearly 10 million people died from cancer …
oncobites.blog
January 28, 2026 at 6:55 PM
Microplastics have been found in our blood, lungs, and brains, and their presence poses a serious health risk. So how do they connect to cancer development? New findings are suggesting two alarming scenarios. Victoria Gnazzo writes.

oncobites.blog/2026/01/21/p...
Plastic contamination: cause or catalyst in cancer progression?
Reading time: 3 minutes Victoria Gnazzo Pollution Beyond the Ocean For many years, we have seen plastic pollution through heartbreaking images, like whales filled with plastic and turtles caught in…
oncobites.blog
January 21, 2026 at 1:57 PM
Recently, the FDA approved the drug dordaviprone for recurrent H3K27M-mutant diffuse midline glioma. This marks a historic turning point, as it is the first therapy for this rare and extremely aggressive brain tumor. Susy Prieto Huarcaya, PhD writes.

oncobites.blog/2026/01/14/d...
Dordaviprone: The First FDA-Approved Treatment for H3K27M Diffuse Midline Glioma
Reading time: 4 minutes Susy Prieto Huarcaya, PhD For families facing diffuse midline glioma, time often feels painfully short and options even shorter. That’s why the FDA’s approval of dordavipron…
oncobites.blog
January 14, 2026 at 4:00 PM
While it’s known that cancer cells can steal mitochondria from nearby cells, a new study shows that the opposite process - that cancer cells can transfer their mitochondria to healthy cells - is just as possible. Mariella Bodemeier Loayza Careaga writes.

oncobites.blog/2026/01/07/c...
Cancer Cell Mitochondria: Sneaky Agents that Reprogram Healthy Cells Into Cancer Buddies
Reading time: 4 minutes Mariella Bodemeier Loayza Careaga If people were asked to name an organelle inside the cell, the word “mitochondria” would certainly pop into most people’s heads. While we a…
oncobites.blog
January 7, 2026 at 1:55 PM
Multi-cancer early detection (MCED) tests can detect various cancers at earlier stages using a single blood sample. MCED tests have the potential to revolutionize cancer screening by identifying a wider spectrum of cancers. Preeti Prangya Panda writes.

oncobites.blog/2025/12/22/m...
Multi-Cancer Early Detection (MCED): The Next Frontier in Cancer Diagnostics
Reading time: 9 minutes Preeti Prangya Panda Cancer is the leading cause of mortality worldwide, with about 10 million deaths annually. Treatment outcomes are normally stage-sensitive, i.e., the so…
oncobites.blog
December 22, 2025 at 1:58 PM
A past European Cancer Anaemia Survey found that 73% of patients with multiple myeloma were also diagnosed with anemia. What could the connection be between these two blood-related conditions? Libby-Ann Harpaul-Sahadeo writes.

oncobites.blog/2025/12/17/m...
Multiple Myeloma and Anemia: The Critical Connection
Reading Time: 3 mins  Libby-Ann Harpaul-Sahadeo  What is Multiple Myeloma?  Multiple myeloma (MM) is a blood cancer that may sometimes present as tumors called plasmacytomas, which a…
oncobites.blog
December 17, 2025 at 4:15 PM
How well do you know about current therapies and ongoing developments for B-cell lymphomas? This is a chance to test your knowledge and learn more directly afterwards! (special: includes a pre- and post-article quiz activity) Néstor Zumaya writes.

oncobites.blog/2025/12/10/p...
Primary refractory and relapsed diffuse large B-cell lymphoma: current treatment options and ongoing developments, an activity
Reading time: 13 minutes (special: includes a pre- and post-article quiz activity!) Néstor Zumaya Image from: Bock AM, Narendranath Epperla. Therapeutic landscape of primary refractory and relapsed…
oncobites.blog
December 10, 2025 at 2:43 PM
Ovarian cancer is the 8th most common malignancy among women and females worldwide. Because this cancer can provoke an immune response, future innovations in cancer treatment strategies are shifting towards emerging immunotherapies. Lubna Najm writes.

oncobites.blog/2025/12/03/i...
Immunotherapies for Ovarian Cancer Treatment
Reading time: 7 minutes Lubna Najm Ovarian cancer is one of the top ten most common malignancies to affect women and females worldwide (NIH National Cancer Institute, 2025; Wang et al., 2025), with…
oncobites.blog
December 3, 2025 at 8:59 PM
The best screening test for colorectal cancer is the one that actually gets done. Capsule and robotic-assisted colonoscopy are making that easier, addressing barriers that have kept many people from getting screened. Maanya Rajasree Katta writes.

oncobites.blog/2025/11/26/w...
Will Robots Replace Colonoscopies? Latest Insights into Robotic and Capsule Endoscopy Technologies
Reading time: 5 minutes Maanya Rajasree Katta Introduction If you have delayed a colonoscopy, you are not alone. The preparation is lengthy, the cleanse is uncomfortable, and sedation can disrupt a…
oncobites.blog
November 26, 2025 at 5:59 PM
Precision oncology is advancing faster than the healthcare infrastructure meant to deliver it. This gap is more representative of real consequences for patient survival, quality of life, and health equity. Shashank Gidipally, PharmD writes.

oncobites.blog/2025/11/19/b...
Bringing Precision Cancer Care Closer to Patients
Reading time: 6 minutes Shashank Gidipally, PharmD. Challenge of Bringing Precision Oncology to Skin Cancer Care in Community Settings In the last decade, skin cancer treatment has gone under a big…
oncobites.blog
November 19, 2025 at 4:29 PM
OncoBites is back for the next writing cycle! Stay tuned weekly for the latest in cancer research in bite-sized pieces like this!
November 12, 2025 at 8:38 PM
Taxanes are chemotherapy drugs that work by inhibiting the function of cytoskeletal microtubules in cancer cells. But what happens if a toxic dosage is given? Libby-Ann Harpaul-Sahadeo writes.

oncobites.blog/2025/11/12/t...
The Right Dosage of Taxanes – What happens after a Taxane toxicity?
Reading Time: 3 minutes Libby-Ann Harpaul-Sahadeo  Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. It is most often used to treat cancer. Taxan…
oncobites.blog
November 12, 2025 at 8:37 PM
October 30, 2025 at 7:06 PM
And that’s a wrap on our last cycle! OncoBites will be taking a short break from publishing to prepare for the new writing cycle. Thank you to all our contributors and readers so far, and we’ll be back with new content soon!
October 2, 2025 at 3:22 PM
Preclinical oncology imaging is no longer a complementary tool, but an essential component of oncology drug development. Bethany Cooper writes.

oncobites.blog/2025/09/24/t...
The role of preclinical oncology imaging in accelerating cancer drug development
Keyword: Preclinical oncology imaging Reading time: 6 minutes Bethany Cooper Introduction With almost 10 million deaths from cancer in 2020, it is the leading cause of death globally, accounting fo…
oncobites.blog
September 25, 2025 at 11:15 AM
Researchers at UCLA proposed an interesting approach to CAR-T cell therapy: using focused ultrasound to only activate CAR-T cells within a tumor. Restricting CAR-T cell activity would theoretically limit its off-target & toxic effects. Anthony Tao writes.

oncobites.blog/2025/09/17/u...
Ultrasound-controlled CAR-T cells to fight solid tumors
Reading time: 5 minutes Anthony Tao Introduction For cancer to successfully grow, one of the major obstacles it must face is the immune system. Cells of the immune system, such as T cells, have nat…
oncobites.blog
September 17, 2025 at 11:32 PM
The dependence of cancer cells on various altered metabolic pathways can be exploited for therapeutic purposes. 1 new therapeutic approach is adipose manipulation transplantation, which can potentially suppress cancer cell proliferation. Colin Ong writes.

oncobites.blog/2025/09/10/a...
A New Potential Therapeutic Approach Targeting Cancer Metabolism: Adipose Manipulation Transplantation (AMT)
Reading time: 8 minutes Colin Ong Altered Metabolism in Cancer Cells Metabolic rewiring is one of the key features of cancer cells1. These cells display altered metabolism as a way to meet their co…
oncobites.blog
September 10, 2025 at 7:11 PM
A recent publication illustrates the power of data sharing from tissue and data collected in three clinical trials. Patty Spears writes.

oncobites.blog/2025/09/03/p...
Power of Data Sharing
Reading time: 3 minutes Patty Spears One of the most valuable contributions a patient can make to science is to donate tumor tissue for research. It is important to use the tissue in research in a …
oncobites.blog
September 3, 2025 at 6:28 PM
In a recent study, scientists have found a clear presence of immune cells, particularly T cells, in the cranial bones of patients with glioblastoma before surgery. Anna Salamero Boix writes.

oncobites.blog/2025/08/27/s...
Skull bone marrow as a source for immune cells in glioma
Reading time: 5 minutes Anna Salamero Boix The tumor microenvironment has emerged as a potential therapeutic target in cancer therapy. Within the tumor microenvironment, tumor-associated immune cel…
oncobites.blog
August 27, 2025 at 1:29 PM
Vaccines have been recognized as promising chemotherapeutic instruments. Advances in how we look for & select antigens, as well as new platforms & delivery methods, pave the way for developing more specific & potent cancer vaccine options. Mariella Careaga writes.

oncobites.blog/2025/08/20/a...
oncobites.blog
August 20, 2025 at 3:50 PM
Taurine is one of the most important ingredients in energy drinks. In a novel study, researchers have found that taurine is not just an additive but rather a key player in the metabolic potential of cancer stem cells. Preeti Prangya Panda writes.

oncobites.blog/2025/08/13/d...
Do Energy Drinks Cause Cancer? Exploring the Latest Research
Reading time: 7 minutes Preeti Prangya Panda Energy drinks are treated like a fast, accessible, and powerful tool to regain energy. Their popularity is undeniable. More than 38% of young adults use…
oncobites.blog
August 13, 2025 at 5:43 PM
We are once again opening our call for authors! Interested in joining us? Please fill out this form by August 22:

docs.google.com/forms/d/e/1F...

If you are unable to write with us this cycle but still wish to be on the list for future calls, please still fill out the form. Thank you!
August 8, 2025 at 4:11 PM
Liquid biopsy is a non-invasive blood-based test that may help increase accessibility to screening & improve early detection of colorectal cancer in younger adults. It may also help to improve outcomes after a cancer diagnosis. Nicole Bowens, PhD writes.

oncobites.blog/2025/08/06/c...
Could Liquid Biopsy Improve CRC Screening Rates and Care After Diagnosis for Younger Adults?
Reading time: 6 minutes Nicole Bowens, PhD The incidence of colorectal cancer (CRC) is currently rising in adults aged 20 to 49 years.1 Increasing accessibility to screening may help improve early …
oncobites.blog
August 6, 2025 at 5:46 PM
A recent study has found that a specific type of immune cell, Vd1-gd T cells, can help predict which patients are more likely to respond favorably to immunotherapy treatments. Joycelyn Ghansah, MA, MPH writes.

oncobites.blog/2025/07/30/a...
Advancing Immunology Therapy: Early Prediction of Skin Cancer Patients’ Chances of Responding to Treatment and Trials on Prednisone and Sirolimus for Kidney Transplant Recipients
Reading time: 5 minutes Joycelyn Ghansah, MA, MPH Active treatments like immunotherapy are used for various cancers, including melanoma, commonly known as skin cancer. Unfortunately, only about hal…
oncobites.blog
July 30, 2025 at 3:14 PM